3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione has been researched along with Cancer of Cervix in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adcock, LL; Blessing, J; Homesley, HD; Thigpen, JT | 1 |
| Blessing, JA; Fowler, WC; Hatch, K; Thigpen, JT | 1 |
1 trial(s) available for 3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione and Cancer of Cervix
| Article | Year |
|---|---|
Phase II trials of cisplatin and piperazinedione as single agents in the treatment of advanced or recurrent non-squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.
Topics: Carcinoma; Cisplatin; Drug Evaluation; Female; Humans; Neoplasm Recurrence, Local; Piperazines; Uterine Cervical Neoplasms | 1986 |
1 other study(ies) available for 3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione and Cancer of Cervix
| Article | Year |
|---|---|
Phase II trial of piperazinedione (NCS 135758) in the treatment of advanced or recurrent squamous cell carcinoma of the cervix. A Gynecologic Oncology Group study.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Carcinoma, Squamous Cell; Drug Evaluation; Female; Humans; Leukocyte Count; Leukopenia; Middle Aged; Neoplasm Recurrence, Local; Piperazines; Thrombocytopenia; Uterine Cervical Neoplasms | 1983 |